Blue Trust’s Regencell Bioscience RGC Stock Holding History
Bought
Maintained
Sold
Other funds holding RGC
Blue Trust's RGC Position: Q3 2026 in Review
Blue Trust sold out of Regencell Bioscience (RGC) in Q3 2026, closing a stake of 216 shares — an estimated $1.32K sold.
Blue Trust first reported a position in RGC in Q4 2025 and held it in 3 quarters. The position peaked at $5.49K in Q1 2026. 24 funds tracked by Wall St. Rank hold RGC as of Q3 2026.
- Blue Trust reported no remaining Regencell Bioscience position as of Q3 2026 after selling out during the quarter.
- Blue Trust sold 216 Regencell Bioscience shares in Q3 2026, an estimated $1.32K.
- Blue Trust first reported a position in Regencell Bioscience in Q4 2025 and held it in 3 quarters.
- Blue Trust's Regencell Bioscience position peaked at $5.49K in Q1 2026.
- 24 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.